USciences’ PharmD Program Achieves Continued Accreditation from ACPE

Written by Brian Kirschner
Published on February 7, 2018

Pharmacy StudentsUniversity of the Sciences has received notification from the Accreditation Council for Pharmacy Education (ACPE) that the University’s doctor of pharmacy program accreditation has been extended to June 30, 2023.

The announcement restores the customary accreditation term of eight years between comprehensive evaluations. The review was based upon the focused site visit in October 2017, the Philadelphia College of Pharmacy’s written report, and other communications received from the institution following the 2014-2015 comprehensive study.

The Accreditation Action and Recommendations report of January 2018 noted “This accreditation action was taken in recognition of the progress made since the last accreditation review and with confidence that existing College and programmatic needs will continue to be addressed in a timely manner and to the satisfaction of the ACPE Board of Directors.”

“We are very pleased with the outcome of ACPE’s accreditation announcement,” Patricia Ryan Audet P’76, PharmD'78, who has been serving as interim dean since May 2017, said. “During our successful site visit with the ACPE accreditation team, we were we were able to highlight the new competency-driven curriculum, the systems that we have put in place for assessment, and the co-curricular activities of professionalism, career development, leadership and community service for students that are the foundations of our students’ excellence.”

The new competency-driven curriculum for pharmacy students is a complete redesign of the doctor of pharmacy students’ courses and assessments aimed at ensuring that PCP’s doctor of students demonstrate the competencies that will make them practice ready as pharmacists prior to graduation.

Other factors that weighed on the ACPE decision included the new facilities and resources such as the third-floor renovations to the Integrated Professional Education Complex (IPEX) and the Pharmacology/Toxicology Center (PTC) student teaching laboratories. Dr. Audet also noted that the University was able to emphasize how faculty resources were properly aligned with student needs.

“All those involved with the PharmD program and across the University should be very proud of this achievement,” Dr. Audet said.

The PharmD program was found to be compliant with all ACPE standards.


Categories: Announcement, News, Academics, Philadelphia College of Pharmacy, Department of Pharmaceutical Sciences, Pharmaceutical Sciences, Pharmaceutics, Pharmacology and Toxicology, Department of Pharmacy Practice, Pharmacy, Pharmacy Administration

Share ArticleShare